Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
---|
11/14/1996 | CA2220498A1 Pharmaceutical composition comprising lactobacillus plantarum and arginine |
11/14/1996 | CA2220472A1 Genetically treated animals |
11/14/1996 | CA2220399A1 .beta.-adrenergic agonists |
11/14/1996 | CA2220358A1 Transdermal therapeutic system (tts) for the administration of testosterone |
11/14/1996 | CA2220052A1 Use of nonsteroidal anti-inflammatory agents to improve the physiological compatibility of particular pharmaceutical preparations |
11/14/1996 | CA2220034A1 Methods for inhibiting bone loss |
11/14/1996 | CA2219973A1 Peptidyl compounds and their therapeutic use |
11/14/1996 | CA2219771A1 Compositions containing bismuth, for the treatment and prevention of gastrointestinal disorders |
11/14/1996 | CA2219758A1 Compositions comprising bismuth and one or more antimicrobials, for the treatment and prevention of gastrointestinal disorders |
11/14/1996 | CA2219397A1 Combination of methotrexate and tenidap for the treatment of rheumatoid arthritis |
11/14/1996 | CA2219354A1 Prevention of tooth loss by the administration of alendronate or its salts |
11/14/1996 | CA2218916A1 Dialkyltiacumicin compounds |
11/14/1996 | CA2218529A1 Nucleic acids for treating obesity |
11/14/1996 | CA2218360A1 Nitric oxide synthase inhibitors derived from cyclic amidines |
11/14/1996 | CA2218088A1 Spirocyclic and bicyclic diazinyl and carbazinyl oxazolidinones |
11/14/1996 | CA2217860A1 Benzothiazoles and benzoxazoles, pharmaceutical compositions containing these compounds and their use and processes for preparing them |
11/14/1996 | CA2216877A1 Alpha-(substituted alkylphenyl)-4-(hydroxydiphenylmethyl)-1-piperidine butanol derivatives, their preparation and their use as anti-histamines, anti-allergy agents and bronchodilators |
11/14/1996 | CA2194756A1 Novel deazapurine derivatives; a new class of crf1 specific ligands |
11/13/1996 | EP0742218A1 Pyrrolopyridazine derivative |
11/13/1996 | EP0742216A2 Cyclic amide derivatives |
11/13/1996 | EP0742215A1 Cillianon, antibiotic from penicillin spe., and chemical derivatives thereof, method for their preparation and application |
11/13/1996 | EP0742214A1 Novel seco-D steroids active in the cardiovascular system and pharmaceutical compositions containing same |
11/13/1996 | EP0742210A1 2-mercaptobenzimidazole derivative and antihyperlipemic or antiarteriosclerotic agent containing the same |
11/13/1996 | EP0742208A1 2-Ureido-benzamide derivatives |
11/13/1996 | EP0742207A1 2-(Indan-1-one-2-yl-alkyl)-1-phenylalkyl-piperidines and processes for their preparation |
11/13/1996 | EP0742203A2 Vitamin D compounds and method of preparing these compounds |
11/13/1996 | EP0742022A1 Biologically compatible hydrogel |
11/13/1996 | EP0742015A1 Prodrugs for beta-lactamase and uses thereof |
11/13/1996 | EP0742012A2 Pharmaceutical composition containing substance inhibiting HSP47 production |
11/13/1996 | EP0742011A1 Percutaneously absorbable preparation |
11/13/1996 | EP0742010A2 Benzoquinolin-3-ones to inhibit bone loss |
11/13/1996 | EP0742009A2 Compounds active against bacteria, mycoses and viruses |
11/13/1996 | EP0742008A1 Controlled release pharmaceutical formulations |
11/13/1996 | EP0742006A1 Non-aqueous emollient iodophor formulations |
11/13/1996 | EP0742005A2 Skin care compositions containing fatty acid amides and retinol or retinyl ester |
11/13/1996 | EP0742004A2 Substances effective against bacteria, mycosis and viruses |
11/13/1996 | EP0742002A1 Artificial tanning compositions |
11/13/1996 | EP0741970A1 Bactericidal composition |
11/13/1996 | EP0741785A1 Methods and compositions for stimulating bone cells |
11/13/1996 | EP0741783A1 Vertebrate embryonic pattern-inducing hedgehog-like proteins |
11/13/1996 | EP0741748A1 Monoclonal antibodies specific to vegf receptors and uses thereof |
11/13/1996 | EP0741741A1 Modified oligonucleotides |
11/13/1996 | EP0741737A1 Watersoluble azole antifungals |
11/13/1996 | EP0741732A1 Process for the preparation of a salt of clavulanic acid |
11/13/1996 | EP0741729A1 Antitumour tetracyclic compounds |
11/13/1996 | EP0741728A1 Improved process for synthesizing carbapenem intermediates |
11/13/1996 | EP0741726A1 Substituted 3-arylidene-7-azaoxindole compounds and process for their preparation |
11/13/1996 | EP0741725A1 Indole derivatives as 5-ht 1? agonists |
11/13/1996 | EP0741724A1 Neuroprotective chroman compounds |
11/13/1996 | EP0741723A1 Triazole derivatives |
11/13/1996 | EP0741722A1 Triazole derivatives |
11/13/1996 | EP0741721A1 Phenylpyrrole derivatives and their use as dopamine d3 antagonists |
11/13/1996 | EP0741719A1 Intermediate and process for making |
11/13/1996 | EP0741716A1 Delta 12,13 -iso-taxol analogs, antineoplastic use and pharmaceutical compositions containing them |
11/13/1996 | EP0741715A1 Novel human leukocyte elastase (hle) inhibitors, and related pharmaceutical compositions and methods of use |
11/13/1996 | EP0741712A1 Process for making hiv protease inhibitors |
11/13/1996 | EP0741711A1 Tricyclic compounds capable of inhibiting tyrosine kinases of the epidermal growth factor receptor family |
11/13/1996 | EP0741709A1 Aromatic 2-amino-imidazole derivatives as alpha-2a adrenoceptor agonists |
11/13/1996 | EP0741708A1 Cyanoguanidines as k-channel blockers |
11/13/1996 | EP0741707A1 SUBSTITUTED AROMATIC COMPOUNDS AS c.AMP PHOSPHODIESTERASE- AND TNF-INHIBITORS |
11/13/1996 | EP0741705A1 4-(2-(3-aryloxy-2-hydroxypropylamino alkyloxy)-5-nitrophenyl)-1,4-dihydropyridines as antihypertensive agents |
11/13/1996 | EP0741704A1 Aralkylamino substituted azacyclic therapeutic agents |
11/13/1996 | EP0741699A1 A pharmaceutical product comprising a salicylate of an esterifiable ace-inhibitor |
11/13/1996 | EP0741697A1 Amino acid derivatives and their use as phospholipase a2 inhibitors |
11/13/1996 | EP0741696A1 Malarial aspartic protease inhibitors |
11/13/1996 | EP0741687A1 Leukotriene b 4? derivatives, methods of preparing them and their use as drugs |
11/13/1996 | EP0741686A1 New leukotriene b 4? derivatives, methods of preparing them and their use as drugs |
11/13/1996 | EP0741578A1 Human growth hormone |
11/13/1996 | EP0741574A1 Oral dosage form containing colestipol as a carrier and acidic active substances and a process for producing the same |
11/13/1996 | EP0741573A1 Use of diesters of muramyl peptides in oral form as immunostimulating agents |
11/13/1996 | EP0741572A1 AGENT, INTENDED FOR TRANSDERMAL ADMINISTRATION, CONTAINING 14$g(a),17$g(a)-ETHANOESTRA-1,3,5(10)-TRIENE-3,17$g(b)-DIOL |
11/13/1996 | EP0741571A1 Use of 2- 4-(azolylbutyl)piperazinyl-(methyl)]benzimidazole derivatives for preparing drugs for treating or preventing asthma |
11/13/1996 | EP0741570A1 Method for preventing or reducing photosensitivity and/or phototoxicity reactions to medications |
11/13/1996 | EP0741569A1 Naphthylisoquinoline alkaloids, pharmaceutical compositions containing them and their use for the treatment of malaria |
11/13/1996 | EP0741568A1 Inhibition of arthritis by l-type calcium channel antagonists |
11/13/1996 | EP0741567A1 Inhibition of smooth muscle migration and proliferation with hydroxy carbazole compounds |
11/13/1996 | EP0741566A1 Use of amino acids for the treatment and prophylaxis of pathogenic effect caused by intracellular calcium overload |
11/13/1996 | EP0741565A1 Process for producing s(+)-ibuprofen particles |
11/13/1996 | EP0741563A1 Compositions for treatment of glaucoma comprising pilocarpine and a beta-blocker |
11/13/1996 | EP0683777B1 Oxindole 1-[n-(alkoxycarbonyl)]carboxamides and 1-[n-carboxamido]carboxamides as intiinflammatory agents |
11/13/1996 | EP0678022B1 Application of riluzole as a radiorestorer |
11/13/1996 | EP0638585B1 5-o-desosaminylerythronolide a derivative |
11/13/1996 | EP0489850B1 New bis-platinum complexes as chemotherapeutic agents |
11/13/1996 | EP0357673B1 Antibiotic reuterin |
11/13/1996 | EP0190292B2 Pharmaceutical preparation |
11/13/1996 | CN1135758A Novel oligosaccharide-containing 14-aminosteroid compounds and novel diastereoselective aminosteroid process chemistry |
11/13/1996 | CN1135757A Novel deoxy and oxygen-substituted sugar-containing 14-aminosteroid compounds |
11/13/1996 | CN1135756A Ganglioside GM3 analog Having sialic acid residue fluorinated at the 9-position and intermediate thereof |
11/13/1996 | CN1135754A Therapeutic agents |
11/13/1996 | CN1135753A Imidazo |1,5-1¨ quinolines for treatment of anxiety and sleep disorders |
11/13/1996 | CN1135752A Easters of substituted-hydroxyacetyl piperazine phenyl oxazolidinones |
11/13/1996 | CN1135750A Novel carbamate compounds and processes for preparing the same |
11/13/1996 | CN1135720A Biodegradable medicinal polymer assembly with supermolecular structure |
11/13/1996 | CN1135719A Estramustine formulations with improved pharmaceutical properties |
11/13/1996 | CN1135716A Percutaneously absorbable preparation |
11/13/1996 | CN1135715A Novel composition |
11/13/1996 | CN1135488A Application of 19,11 beta-bridged sterodal compound in pharmaceutical working |
11/13/1996 | CN1135486A Anti-tanning agent, and light-protection cosmetic composition containing said agent and application thereof |
11/13/1996 | CN1135485A 2,9-di-substituted pur-6-ones compound |
11/13/1996 | CN1135484A 3-alkylcarbonyl-thiadiazineone |